The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors

Matrix metalloproteinases (MMPs) have been demonstrated to have both detrimental and protective functions in inflammatory diseases. Several MMP inhibitors, with the exception of Periostat(®), have failed in Phase III clinical trials. As an alternative strategy, recent efforts have been focussed on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Nabangshu, Benko, Colette, Gill, Sean E., Dufour, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823758/
https://www.ncbi.nlm.nih.gov/pubmed/33396445
http://dx.doi.org/10.3390/ph14010031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823758/
https://www.ncbi.nlm.nih.gov/pubmed/33396445
http://dx.doi.org/10.3390/ph14010031

Ejemplares similares